Vanguard Fiduciary Trust’s ABVC BioPharma ABVC Stock Holding History

Vanguard Fiduciary Trust’s Portfolio ABVC Stock Details ABVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$154K	Hold	97,363	–	–	﹤0.01%	3646
2026 Q1	$94.4K	Buy	+97,363	New	+$161K	﹤0.01%	3723

Other funds holding ABVC

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust's ABVC Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its ABVC BioPharma (ABVC) position steady in Q2 2026 at 97,363 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #3646.

Vanguard Fiduciary Trust first reported a position in ABVC in Q1 2026 and has held it in 2 quarters since. 15 funds tracked by Wall St. Rank hold ABVC as of Q2 2026.

Vanguard Fiduciary Trust held 97,363 shares of ABVC BioPharma worth $154K as of Q2 2026.
Vanguard Fiduciary Trust left its ABVC BioPharma share count unchanged in Q2 2026.
ABVC BioPharma made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3646 holding.
Vanguard Fiduciary Trust first reported a position in ABVC BioPharma in Q1 2026 and has held it in 2 quarters since.
15 funds tracked by Wall St. Rank held ABVC BioPharma as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.